Trinity Biotech Plc (TRIB)

5.69 -0.63 (-9.97%) USD  |  NASDAQ  |  Oct 02, 16:00
5.46 -0.23 (-4.04%) After-Hours: 20:00
More

Trinity Biotech Cash from Operations (TTM)

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2010. Start Trial.
Date Value
December 31, 2025 -6.256M
September 30, 2025 -1.427M
June 30, 2025 -7.175M
March 31, 2025 -8.584M
December 31, 2024 -10.44M
September 30, 2024 -14.69M
June 30, 2024 -15.39M
March 31, 2024 -18.64M
December 31, 2023 -19.18M
September 30, 2023 -17.59M
June 30, 2023 -12.09M
March 31, 2023
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021 8.394M
September 30, 2021 15.39M
June 30, 2021 22.80M
March 31, 2021 24.34M
December 31, 2020 19.76M
September 30, 2020 3.648M
June 30, 2020 1.25M
March 31, 2020 -0.105M
December 31, 2019 1.421M
Date Value
September 30, 2019 8.985M
June 30, 2019 6.955M
March 31, 2019 4.971M
December 31, 2018 2.726M
September 30, 2018 2.004M
June 30, 2018 3.472M
March 31, 2018 5.197M
December 31, 2017 4.65M
September 30, 2017 1.847M
June 30, 2017 5.462M
March 31, 2017 4.226M
December 31, 2016 5.624M
September 30, 2016 14.94M
June 30, 2016 10.85M
March 31, 2016 10.93M
December 31, 2015 10.95M
September 30, 2015 13.96M
June 30, 2015 15.53M
March 31, 2015 16.73M
December 31, 2014 15.88M
September 30, 2014 7.536M
June 30, 2014 5.804M
March 31, 2014 7.089M
December 31, 2013 9.345M
September 30, 2013 14.78M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
DBV Technologies SA -169.35M
Cellectis SA -42.00M
Akari Therapeutics Plc -10.74M
Autolus Therapeutics Plc -224.98M
Evaxion AS --